Login

Journal Front Page

News & Events

  • Call for article for January 2025 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 4 (October 2024 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

COLON DRUG DELIVERY SYSTEM AND THEIR BENEFITS AND THE CARRIERS FOR DELIVERY OF DRUGS TO COLON: A REVIEW

Supratik Ray1*, Shivakant Shukla1, Dr. A.K. Singhai1, Dr. Subhendu Sekhar Mishra2

1Lakshmi Narain College of Pharmacy, Bhopal (M.P.)

2Kalinga Biomedical Research Institute & Training Establishment, Sambalpur, Odisha

3Gayatri College of Pharmacy, Sambalpur, Odisha, India.

ABSTRACT

The colon drug delivery system is undergoing a designed novel drug delivery system. In this system the drug directly absorbed in colon sites. Normally protein or those drugs which are less absorbed in the stomach or small intestine that type of drugs are targeted to colon site. In the colon site, the bioavailability of drugs is higher than the stomach. Through colon drug delivery system inflammatory bowel disease (IBD), Chron’s disease, as well as asthma and in serious conditions such as colonic cancer. Into the colon through model novel drug formulation drugs are directly targeted to the colon. This review shows the study of benefit criteria for colon targeting of drugs and also the study of formulation type and factor for colon-specific drug delivery systems (CSDDS).

Keywords: Colon drug delivery system, Inflammatory bowel disease, pH of the colon.


[Full Text Article]